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Background
Pacemaker/AICD imaging is currently being performed on
patients in the MRI environment. A vigilant team consist-
ing of the (Cardiologist, EP staff, and technologists) with
close patient monitoring and supervision is making such
an unmentionable procedure a success. However, is the
diagnosis from imaging these patients adding valuable irre-
futable information to merit such a risk?
Methods
A total of 48 patients were imaged on a GE CV/i Excite
Version 12, 1.5 T system (GE, Milwaukee, WI). 8 patients
had an AICD, 7 had an AICD/Pacemaker, 2 had a single
pacemaker lead, 2 REVO pacemakers and 29 patients had
a traditional dual-chamber pacemaker. A specific criteria
was followed for all the patients undergoing this procedure
to scrutinize if the final diagnosis provided additional
information in patient care. A checklist of three questions
were gathered and answered after the final interpretation
of the MRI. Does the diagnosis change? Does the MRI
provide additional information to the existing diagnosis?
Does patient management change? If ‘yes’ was answered
any of the above questions it was considered that the MRI
scan was of value to patient diagnosis.
Results
Regarding the population, of the 48 patients imaged, 36
(75%) were neurology cases and 12(25%) were cardiac/
vascular cases. After reviewing the results from the 36
neurology cases and comparing the results from prior
studies (CT, angio, EEG and/or myelogram) 16 (45%) out
of the 36 showed that the MRI not only provided addi-
tional information but changed the original diagnosis and
in turn their course of medical treatment. 8 patients
(22%) provided additional information to the diagnosis.
Thus a total of 24 patients (67%) showed that the MRI
scan was of value to the final diagnosis. In 12(33%) out of
the 36 patients imaged MRI did not provide further
information but confirmed the original diagnosis. The 12
cardiac cases were also compared to prior studies (heart
cath, TEE, TTE and stress) and in 4 patients (33%) the
MRI provided additional information to change the origi-
nal diagnosis and also patient management. The remain-
ing 8 (67%) showed that extra information was gathered
by having the Cardiac MRI procedure. In essence, 100%
of the cardiac population benefited by having an CMR
done.
Conclusions
The use of PM/AICD imaging in MRI remains controver-
sial but as the lead/generator technology has improved,
increased confidence in its use is found. Herein, we show
that MRI procedures on carefully selected patients with
pacemakers/AICD’s are beneficial and substantially add
valuable irrefutable information to patient diagnosis and
management We propose that not only are Pacemakers/
AICD’s no longer forbidden in the MRI environment but
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